Thomas Grader Beck

Medicine & Life Sciences

1. T-Lymphocytes 100%
2. Patient Reported Outcome Measures 84%
3. 4-sulfated N-acetyl-lactosamine 76%
4. Cyclic AMP 75%
5. Isoantigens 70%
6. Mixed Connective Tissue Disease 54%
7. Poly (ADP-Ribose) Polymerase-1 53%
8. Eye 51%
9. Large-Core Needle Biopsy 50%
10. Antibodies 49%
11. Raynaud Disease 48%
12. Biopsy 46%
13. Psoriatic Arthritis 46%
14. Graft vs Host Disease 46%
15. Salivary Glands 45%
16. Electronic Health Records 45%
17. Psychological Burnout 45%
18. Systemic Scleroderma 43%
19. Information Systems 42%
20. Cell Transplantation 41%
21. Allogeneic Cells 41%
22. Helper-Inducer T-Lymphocytes 39%
23. Cell Cycle 39%
24. Lip 38%
25. Autoimmunity 37%
26. Vascular Diseases 37%
27. Dry Eye Syndromes 36%
28. Evaluation Studies 34%
29. Biochemistry 34%
30. Lung Diseases 34%
31. Critical Care 33%
32. Carbohydrates 33%
33. Lymphoma 32%
34. Safety 29%
35. T-Cell Antigen Receptor 28%
36. Medicine 28%
37. Quality of Life 26%
38. Placebos 26%
39. HIV 26%
40. Clinical Trials 25%
41. Transplants 22%
42. Morbidity 22%
43. Antigens 21%
44. 1-Methyl-3-isobutylxanthine 21%
45. Lung 20%
46. Health 18%
47. Neoplasms 18%
48. Marginal Zone B-Cell Lymphoma 18%